Humalog®

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

HUMALOG® MIX: Pediatric Use

Humalog premixed insulin has not been studied in pediatric patients.

Detailed Information

The safety and effectiveness of LM75/25 or LM50/50 in patients less than 18 years of age have not been studied.1,2

Enclosed Prescribing Information

HUMALOG® Mix50/50™ (insulin lispro protamine and insulin lispro injectable suspension), for subcutaneous use, Lilly

HUMALOG® Mix75/25™ (insulin lispro protamine and insulin lispro injectable suspension), for subcutaneous use, Lilly

References

1. Humalog Mix75/25 [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.

2. Humalog Mix50/50 [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.

Glossary

LM50/50 = Humalog® Mix50/50 (insulin lispro protamine and insulin lispro injectable suspension)

LM75/25 = Humalog® Mix75/25 (insulin lispro protamine and insulin lispro injectable suspension)

Date of Last Review: October 31, 2018

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical